Astrazeneca plc ADR [AZN] stock prices are up 1.43% to $67.18 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Astrazeneca plc ADR [NASDAQ: AZN] stock has seen the most recent analyst activity on November 20, 2024, when UBS upgraded its rating to a Neutral. Previously, Deutsche Bank upgraded its rating to Hold on November 06, 2024. On September 13, 2024, downgrade downgraded it’s rating to Sell. Goldman started tracking the stock assigning a Buy rating and suggested a price target of $97 on May 30, 2024. Deutsche Bank upgraded its rating to a Hold. Deutsche Bank downgraded its rating to Sell for this stock on February 08, 2024. In a note dated January 23, 2024, Morgan Stanley initiated an Overweight rating and provided a target price of $85 on this stock.
The stock price of Astrazeneca plc ADR [AZN] has been fluctuating between $60.47 and $87.68 over the past year. Currently, Wall Street analysts expect the stock to reach $88 within the next 12 months. Astrazeneca plc ADR [NASDAQ: AZN] shares were valued at $67.18 at the most recent close of the market. An investor can expect a potential return of 30.99% based on the average AZN price forecast.
Analyzing the AZN fundamentals
The Astrazeneca plc ADR [NASDAQ:AZN] reported sales of 51.21B for trailing twelve months, representing a surge of 18.04%. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.17 and Total Capital is 0.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.74.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 66.59 points at the first support level, and at 66.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 67.62, and for the 2nd resistance point, it is at 68.06.
Ratios To Look Out For
It’s worth pointing out that Astrazeneca plc ADR [NASDAQ:AZN]’s Current Ratio is 0.93. As well, the Quick Ratio is 0.71, while the Cash Ratio is 0.19. Considering the valuation of this stock, the price to sales ratio is 4.07, the price to book ratio is 5.12 and price to earnings (TTM) ratio is 32.28.
